Cernilton A® approved by KFDA in South Korea
Press release February 27, 2024. Cernilton A® approved by KFDA in South Korea AB Cernelle, in close and trusted partnership with DongKoo Bio&Pharma Co, Ltd, a leading Korean pharmaceutical company with focus in urology, [Read more]
Backahill enters into an agreement to sell AB Cernelle
Press release 16 November 2021. Backahill enters into an agreement to sell AB Cernelle. Backahill AB has entered into an agreement to sell all shares in the subsidiary AB Cernelle to the German pharmaceutical [Read more]
Cernelle enters China
Cernelle enters China. AB Cernelle, in partnership with MeiRui, a leading Chinese pharmaceutical company specialising in urology, has received approval for Shenitong®, which is an herbal medicinal product for the treatment of benign prostate [Read more]
Cernelle – a 100% fossil-free company
Cernelle – a 100% fossil-free companyBiogas instead of natural gas, charging posts for cars, switching to LED lighting and detailed energy measurement. Following several years of concerted effort to reduce its environmental impact, pharmaceutical company [Read more]
COVID-19 and supply of medicines
COVID-19 and supply of medicines As the coronavirus outbreak continues to evolve globally, Cernelle is implementing the necessary precautions to safeguard the continued supply of our medicines and provide treatment for the people who [Read more]
Cernitol introduced to French urologists and pharmacists in Toulouse.
Cernitol introduced to French urologists and pharmacists in Toulouse. Cernitol 47 mg is now available for sale in France. During a scientific seminar held by Cernelle September 10th in Toulouse, Cernitol was introduced successfully [Read more]
Cernitol Novum is launched in France
Cernitol Novum is launched in France Cernitol Novum is now available in France under the brand name Cernitol 47 mg. Cernelle is expanding internationally by entering a large and promising market. The French have great [Read more]
New facilities to manage ongoing expansion
New facilities to manage ongoing expansionEnd of 2018, Cernelle’s team moved from a traditional to a modern office space and a new laboratory, both about 1000 sqm. Cernelle’s modern and dynamic spaces are designed to [Read more]
Bronze sponsor at the Swedish National Conference of Urology 2018
Bronze sponsor at the Swedish National Conference of Urology 2018 Every year, the Swedish Association of Urology organizes a national conference where about 1 000 participants from all over Sweden gather to share urological [Read more]
AB CERNELLE sponsors the Swedish Association of Urology in Gothenburg.
AB CERNELLE sponsors the Swedish Association of Urology in Gothenburg. Cernitol, a herbal pharmaceutical medicine to treat symptoms caused by benign prostate diseases. Has been more and more recognised in Sweden as an effective [Read more]